72.11.Z - Scientific research and development activities
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 2,6 | 0,3 | 2,4 | 697,7 |
Gross profit (loss) | -1,5 | -2,4 | -3,5 | -42,3 |
EBITDA | ||||
Net profit (loss) | -1,5 | -2,4 | -3,5 | -42,3 |
Cash | ||||
Liabilities and provisions for liabilities | 0 | 0,2 | 5,8 | 2989,9 |
Net income from sale | ||||
Short time liabilities | ||||
Income tax | 0 | 0 | 0 | 0 |
Working assets | 1,1 | 0,3 | 0,9 | 208,7 |
Equity capital | 2,6 | 0,1 | -3,3 | -2895,1 |
Operating profit (EBIT) | ||||
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | -57,4 | -2035,1 | -1977,7 | |
Equity capital to total assets | 100 | 38,9 | -136,5 | -175,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane